Lahoti Overseas (531842)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Low valuation: P/E of 8.21 and P/B of 0.65, with the stock trading well below book value of ₹70.14.
• Positive earnings despite decline: latest quarter delivered ₹4 Cr net profit on ₹100 Cr sales.
• Moderate capital efficiency: ROE of 8.66% and ROCE of 10.89% show the company is not destroying capital.
• Market cap of ₹134 Cr is small, and the implied annual profit of roughly ₹16 Cr makes the price reasonable if earnings stabilise.

Concerns

• Sales growth is negative at -17.49%, and profit growth is also down -5.47%, indicating a deteriorating business trend.
• Piotroski F-Score of 3/9 suggests weak financial health, with red flags in profitability, leverage, or operating efficiency.
• Trading and distribution businesses typically lack pricing power and have thin margins, as seen in the latest 4% net margin.
• Dividend yield of just 0.41% offers little income support while returns on equity remain below 9%.

AI Analysis

At ₹45.90, Lahoti Overseas trades at only 0.65 times its book value of ₹70.14, and the P/E of 8.21 gives an earnings yield greater than 12%. That is the kind of price that catches a Graham-style investor’s attention. But a cheap price is not enough; the business itself must be sound. Here, I see warning signs. Sales have fallen 17.49% and profit has dropped 5.47%. The latest quarter shows ₹100 Cr of sales and ₹4 Cr of net profit, a thin 4% margin. Trading and distribution is a commodity-like business with little pricing power and no durable moat. The Piotroski F-Score of 3 out of 9 tells me the financial health is weak, not improving. ROE is only 8.66% and ROCE is 10.89%, so the company earns a moderate, not exceptional, return on capital. This is not a wonderful business by my standards. However, buying at ₹45.90 means I am paying less than book value for an entity that, on a trailing basis, earned about ₹16 Cr per year. Market cap is ₹134 Cr, so the multiple is low. The asset backing provides some margin of safety if the stated book value is real and not impaired by stale inventory or doubtful receivables. That is the key risk in a distributor: assets may not be worth what the balance sheet says. I would not classify this as a growth stock; it looks more like an asset play with cyclicality. I can be interested only if sales stabilise and working capital remains clean. In Mr. Market’s pessimism, I might find an opportunity, but I need proof before buying.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer